Evidence map›Paper›PMID 34210070›Full record

ReviewMarine drugs2021

Therapeutic Potential of Hemoglobin Derived from the Marine Worm

Fareeha Batool, Eric Delpy, Franck Zal, Elisabeth Leize-Zal, Olivier Huck

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Oxygen carriers affect kidney immunogenicity duringFrontiers in transplantation · 2023
    Article
  17. Review
  18. Larval growth of the polychaeteConservation physiology · 2022
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Fareeha BatoolINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, Fédération de Médecine Translationnelle de Strasbourg (FMTS), 67000 Strasbourg, France.
Eric DelpyHemarina SA, Aéropôle Centre, 29600 Morlaix, France.ORCID 0000-0001-8056-3652
Franck ZalHemarina SA, Aéropôle Centre, 29600 Morlaix, France.
Elisabeth Leize-ZalHemarina SA, Aéropôle Centre, 29600 Morlaix, France.
Olivier HuckINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, Fédération de Médecine Translationnelle de Strasbourg (FMTS), 67000 Strasbourg, France.ORCID 0000-0002-7988-2290
Hemarina (France) · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxygen (O

Indexed as

PolychaetaAnimalsAnti-Inflammatory AgentsAquatic OrganismsHemoglobinsOxidative StressAnti-Inflammatory AgentsHemoglobinsArenicola marinahemoglobin-based oxygen carriersM101therapeutic oxygen carriers

Identifiers

PMID34210070
PMCPMC8304559
OpenAlexW3176893528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.